SI1881967T1 - Substituirane benzo(d)izoksazol-3-il-aminske spojine kot analgetiki - Google Patents

Substituirane benzo(d)izoksazol-3-il-aminske spojine kot analgetiki

Info

Publication number: SI1881967T1
Authority: SI; Slovenia
Prior art keywords: isoxazol; analgesics; amine compounds; substituted benzo; compounds
Prior art date: 2005-05-18

Application number

SI200630725T

Other languages

English (en)

Inventor

Beatrix Merla

Robert Frank

Gregor Bahrenberg

Wolfgang Schroder

Saskia Zemolka

Original Assignee

Gruenenthal Chemie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-18

Filing date

2006-05-18

Publication date

2010-08-31

2006-05-18 Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie

2010-08-31 Publication of SI1881967T1 publication Critical patent/SI1881967T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Psychology (AREA)
Hematology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)

SI200630725T 2005-05-18 2006-05-18 Substituirane benzo(d)izoksazol-3-il-aminske spojine kot analgetiki SI1881967T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE102005023589		2005-05-18
DE102005038947A DE102005038947A1 (de)	2005-05-18	2005-08-16	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
EP06753695A EP1881967B1 (de)	2005-05-18	2006-05-18	Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika
PCT/EP2006/004700 WO2006122800A1 (de)	2005-05-18	2006-05-18	Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika

Publications (1)

Publication Number	Publication Date
SI1881967T1 true SI1881967T1 (sl)	2010-08-31

Family

ID=36699120

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200630725T SI1881967T1 (sl)	2005-05-18	2006-05-18	Substituirane benzo(d)izoksazol-3-il-aminske spojine kot analgetiki
SI200630455T SI1888541T1 (sl)	2005-05-18	2006-05-18	Benzo(d)izoksazol-3-il-aminske spojine in njihova uporaba kot ligandi vaniloidnega receptorja

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI200630455T SI1888541T1 (sl)	2005-05-18	2006-05-18	Benzo(d)izoksazol-3-il-aminske spojine in njihova uporaba kot ligandi vaniloidnega receptorja

Country Status (16)

Country	Link
US (2)	US7977360B2 (sl)
EP (2)	EP1888541B1 (sl)
JP (2)	JP2008540598A (sl)
AT (2)	ATE438633T1 (sl)
AU (1)	AU2006249065B2 (sl)
CA (2)	CA2608386A1 (sl)
CY (2)	CY1109568T1 (sl)
DE (3)	DE102005038947A1 (sl)
DK (2)	DK1888541T3 (sl)
ES (2)	ES2331259T3 (sl)
HK (1)	HK1112238A1 (sl)
PL (2)	PL1888541T3 (sl)
PT (2)	PT1888541E (sl)
RU (1)	RU2416607C2 (sl)
SI (2)	SI1881967T1 (sl)
WO (2)	WO2006122800A1 (sl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005038947A1 (de) *	2005-05-18	2006-11-30	Grünenthal GmbH	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
US20100080773A1 (en)	2008-09-26	2010-04-01	Sdg, Inc.	Orally Bioavailable Lipid-Based Constructs
WO2009096701A2 (en)	2008-01-28	2009-08-06	Amorepacific Corporation	Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
CN102137851B (zh)	2008-07-02	2014-08-27	株式会社爱茉莉太平洋	作为香草素受体拮抗剂的化合物、其异构体或其药学可接受的盐以及包含它们的药物组合物
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
TWI504395B (zh)	2009-03-10	2015-10-21		Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
MX2011008825A (es)	2009-03-10	2011-09-21	Gruenenthal Gmbh	3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
TWI461197B (zh)	2009-03-12	2014-11-21		2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TW201038565A (en)	2009-03-12	2010-11-01	Gruenenthal Gmbh	Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
EP2531510B1 (en)	2010-02-01	2014-07-23	Novartis AG	Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
WO2011092293A2 (en)	2010-02-01	2011-08-04	Novartis Ag	Cyclohexyl amide derivatives as crf receptor antagonists
EP2531490B1 (en)	2010-02-02	2014-10-15	Novartis AG	Cyclohexyl amide derivatives as crf receptor antagonists
KR20120120416A (ko)	2010-02-11	2012-11-01	벤더르빌트 유니버시티	Ｍｇｌｕｒ4 알로스테릭 강화제로서 벤즈이속사졸 및 아자벤즈이속사졸, 조성물, 및 신경 기능이상을 치료하는 방법
ES2537628T3 (es)	2010-08-27	2015-06-10	Grünenthal GmbH	2-Oxiquinolin-3-carboxamidas sustituidas como moduladores de KCNQ2/3
AR082733A1 (es)	2010-08-27	2012-12-26	Gruenenthal Gmbh	2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3
DK2609086T3 (da)	2010-08-27	2015-03-30	Gruenenthal Gmbh	Substituerede 2-oxo- og 2-thioxo-dihydroquinolin-3-carboxamider som KCNQ2/3 modulatorer
AU2011297937B2 (en)	2010-09-01	2015-10-01	Grunenthal Gmbh	Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
JP6014154B2 (ja)	2011-10-31	2016-10-25	ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃ．	ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
CN104093716B (zh)	2011-10-31	2017-06-23	克赛农制药股份有限公司	联芳醚磺酰胺化合物及其作为治疗剂的用途
EP2855428A1 (en)	2012-05-22	2015-04-08	Genentech, Inc.	N-substituted benzamides and their use in the treatment of pain
BR112015000187A2 (pt)	2012-07-06	2017-06-27	Genentech Inc	benzamidas substituídas com n e métodos de uso das mesmas
CN105263490B (zh)	2013-03-14	2018-05-22	基因泰克公司	取代的三唑并吡啶及其使用方法
RU2015143834A (ru)	2013-03-15	2017-04-24	Дженентек, Инк.	Замещенные бензоксазолы и способы их применения
PE20161247A1 (es)	2013-11-27	2016-11-30	Genentech Inc	Benzamidas sustituidas y metodos para usarlas
JP6409067B2 (ja) *	2013-12-20	2018-10-17	ギリアードサイエンシーズ，インコーポレイテッド	イオンチャネルモジュレーターとしての縮合複素環式化合物
EP3166939B1 (en)	2014-07-07	2019-06-05	Genentech, Inc.	Therapeutic compounds and methods of use thereof
JP7323985B2 (ja)	2014-08-13	2023-08-09	オークランドユニサービシーズリミティド	トリプトファンジオキシゲナーゼ（ｉｄｏ１とｔｄｏ）の阻害剤及び治療におけるその使用
EP3233840B1 (en)	2014-12-16	2018-11-21	Eudendron S.r.l.	Heterocyclic derivatives modulating activity of certain protein kinases
US10183938B2 (en)	2014-12-16	2019-01-22	Axovant Sciences Gmbh	Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors
CR20170591A (es)	2015-05-22	2018-05-07	Genentech Inc	Benzamidas sustituidas y métodos para utilizarlas
CN107847494A (zh)	2015-06-10	2018-03-27	阿考温特科学股份有限公司	作为α7‑烟碱乙酰胆碱受体激动剂的氨基苯并异噁唑化合物
EP3334740A4 (en) *	2015-08-12	2019-02-06	Axovant Sciences GmbH	GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF ALPHA 7-NICOTINIC ACETYLCHOLINE RECEPTORS
CN108349997A (zh) *	2015-08-27	2018-07-31	奥克兰联合服务有限公司	色氨酸双加氧酶（ido1和tdo）抑制剂及其在治疗中的用途
MA42683A (fr)	2015-08-27	2018-07-04	Genentech Inc	Composés thérapeutiques et leurs méthodes utilisation
EP3356360A1 (en)	2015-09-28	2018-08-08	Genentech, Inc.	Therapeutic compounds and methods of use thereof
EP3380466A1 (en)	2015-11-25	2018-10-03	Genentech, Inc.	Substituted benzamides useful as sodium channel blockers
US10766858B2 (en)	2016-03-30	2020-09-08	Genentech, Inc.	Substituted benzamides and methods of use thereof
CA3039853A1 (en)	2016-10-17	2018-04-26	Genentech, Inc.	Therapeutic compounds and methods of use thereof
JP2020511511A (ja)	2017-03-24	2020-04-16	ジェネンテック，インコーポレイテッド	ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体
TW202000651A (zh)	2018-02-26	2020-01-01	美商建南德克公司	治療性組成物及其使用方法
WO2019191702A1 (en)	2018-03-30	2019-10-03	F. Hoffmann-La Roche Ag	Substituted hydro-pyrido-azines as sodium channel inhibitors
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
LT3986890T (lt)	2019-06-18	2023-12-11	Pfizer Inc.	Benzizoksazolo sulfonamido dariniai
WO2021110891A1 (en)	2019-12-04	2021-06-10	Syngenta Crop Protection Ag	Pesticidally active fused bicyclic heteroaromatic amino compounds
US20230142606A1 (en)	2020-01-30	2023-05-11	Syngenta Crop Protection Ag	Pesticidally active fused bicyclic heteroaromatic amino compounds
CN112142683B (zh) *	2020-09-01	2022-05-24	成都大学	一种氮杂十一元环化合物及其制备方法、用途以及包含该化合物的药物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL171914B1 (pl) *	1991-03-28	1997-06-30	Eisai Co Ltd	Sposób wytwarzania pochodnych aminy heterocyklicznej PL PL PL PL PL PL PL
US5328920A (en) *	1991-04-17	1994-07-12	Hoechst-Roussel Pharmaceuticals Incorporated	Substituted (pyridinylamino)-indoles
DE69332691T2 (de) *	1992-11-23	2003-12-18	Aventis Pharmaceuticals Inc., Cincinnati	Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen
US5494908A (en) *	1992-11-23	1996-02-27	Hoechst-Roussel Pharmaceutical Incorporated	Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
WO1996039405A1 (en) *	1995-06-06	1996-12-12	Hoechst Marion Roussel, Inc.	Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles as antipsychotic agents
EE04680B1 (et) *	1998-10-06	2006-08-15	Janssen Pharmaceutica N.V.	Tritsklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
AU1818400A (en) *	1998-11-12	2000-05-29	Eli Lilly And Company	Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
EP1135023A4 (en) *	1998-11-12	2003-03-05	Lilly Co Eli	AMINOBENZISOXAZOLE COMPOUNDS AND LIBRARIES THEREOF
PL357108A1 (en) *	1999-07-16	2004-07-12	Bristol-Myers Squibb Pharma Company	Nitrogen containing heterobicycles as factor xa inhibitors
US20030176454A1 (en) *	2000-05-15	2003-09-18	Akira Yamada	N-coating heterocyclic compounds
PL372944A1 (en) *	2001-02-20	2005-08-08	Bristol-Myers Squibb Company	2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
US6855829B2 (en)	2001-02-20	2005-02-15	Bristol-Myers Squibb Company	3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease
US6469042B1 (en) *	2001-02-20	2002-10-22	Bristol-Myers Squibb Company	Fluoro oxindole derivatives as modulators if KCNQ potassium channels
US6593349B2 (en) *	2001-03-19	2003-07-15	Icagen, Inc.	Bisarylamines as potassium channel openers
KR100789567B1 (ko) *	2001-11-06	2007-12-28	동화약품공업주식회사	3-아미도-1,2-벤조이소옥사졸 유도체, 그 염, 제조방법 및 용도
DE10229070A1 (de) *	2002-06-28	2004-01-15	Merck Patent Gmbh	Phenylderivate 5
GB0217757D0 (en) *	2002-07-31	2002-09-11	Glaxo Group Ltd	Novel compounds
JO2696B1 (en) *	2002-12-23	2013-03-03	شركة جانسين فارماسوتيكا ان. في	Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
NZ543614A (en) *	2003-05-22	2009-09-25	Abbott Lab	Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
GB0319150D0 (en)	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
CA2559105A1 (en) *	2004-03-16	2005-09-29	Janssen Pharmaceutica N.V.	Benzisoxazoles
US7759337B2 (en) *	2005-03-03	2010-07-20	Amgen Inc.	Phthalazine compounds and methods of use
DE102005038947A1 (de) *	2005-05-18	2006-11-30	Grünenthal GmbH	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
DE102005026194A1 (de) *	2005-06-06	2006-12-07	Grünenthal GmbH	Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
US7989461B2 (en) *	2005-12-23	2011-08-02	Amgen Inc.	Substituted quinazolinamine compounds for the treatment of cancer

2005
- 2005-08-16 DE DE102005038947A patent/DE102005038947A1/de not_active Withdrawn
2006
- 2006-05-18 WO PCT/EP2006/004700 patent/WO2006122800A1/de active Application Filing
- 2006-05-18 DE DE502006004453T patent/DE502006004453D1/de active Active
- 2006-05-18 SI SI200630725T patent/SI1881967T1/sl unknown
- 2006-05-18 DK DK06742972T patent/DK1888541T3/da active
- 2006-05-18 ES ES06742972T patent/ES2331259T3/es active Active
- 2006-05-18 EP EP06742972A patent/EP1888541B1/de not_active Not-in-force
- 2006-05-18 AT AT06742972T patent/ATE438633T1/de active
- 2006-05-18 PT PT06742972T patent/PT1888541E/pt unknown
- 2006-05-18 AU AU2006249065A patent/AU2006249065B2/en not_active Ceased
- 2006-05-18 EP EP06753695A patent/EP1881967B1/de not_active Not-in-force
- 2006-05-18 PL PL06742972T patent/PL1888541T3/pl unknown
- 2006-05-18 PT PT06753695T patent/PT1881967E/pt unknown
- 2006-05-18 JP JP2008511638A patent/JP2008540598A/ja not_active Ceased
- 2006-05-18 AT AT06753695T patent/ATE466002T1/de active
- 2006-05-18 CA CA002608386A patent/CA2608386A1/en not_active Abandoned
- 2006-05-18 DK DK06753695.3T patent/DK1881967T3/da active
- 2006-05-18 WO PCT/EP2006/004698 patent/WO2006122799A1/de active Application Filing
- 2006-05-18 RU RU2007146385/04A patent/RU2416607C2/ru not_active IP Right Cessation
- 2006-05-18 CA CA002608773A patent/CA2608773A1/en not_active Abandoned
- 2006-05-18 PL PL06753695T patent/PL1881967T3/pl unknown
- 2006-05-18 US US11/914,636 patent/US7977360B2/en not_active Expired - Fee Related
- 2006-05-18 SI SI200630455T patent/SI1888541T1/sl unknown
- 2006-05-18 ES ES06753695T patent/ES2344272T3/es active Active
- 2006-05-18 DE DE502006006854T patent/DE502006006854D1/de active Active
- 2006-05-18 JP JP2008511637A patent/JP2008540597A/ja not_active Ceased
2007
- 2007-11-16 US US11/941,331 patent/US7696238B2/en not_active Expired - Fee Related
2008
- 2008-07-04 HK HK08107419.0A patent/HK1112238A1/xx not_active IP Right Cessation
2009
- 2009-11-05 CY CY20091101144T patent/CY1109568T1/el unknown
2010
- 2010-07-15 CY CY20101100664T patent/CY1110209T1/el unknown

Also Published As

Publication number	Publication date
AU2006249065B2 (en)	2011-04-21
DK1888541T3 (da)	2009-12-07
EP1881967A1 (de)	2008-01-30
AU2006249065A1 (en)	2006-11-23
WO2006122799A1 (de)	2006-11-23
ATE438633T1 (de)	2009-08-15
SI1888541T1 (sl)	2010-01-29
CA2608386A1 (en)	2006-11-23
ATE466002T1 (de)	2010-05-15
PL1881967T3 (pl)	2010-10-29
RU2416607C2 (ru)	2011-04-20
HK1112238A1 (en)	2008-08-29
RU2007146385A (ru)	2009-10-27
ES2331259T3 (es)	2009-12-28
ES2344272T3 (es)	2010-08-23
DE502006004453D1 (de)	2009-09-17
DK1881967T3 (da)	2010-08-16
PT1888541E (pt)	2009-11-10
US20090042945A1 (en)	2009-02-12
US7977360B2 (en)	2011-07-12
CY1110209T1 (el)	2015-01-14
CY1109568T1 (el)	2014-08-13
PL1888541T3 (pl)	2010-01-29
US20080176915A1 (en)	2008-07-24
EP1881967B1 (de)	2010-04-28
CA2608773A1 (en)	2006-11-23
US7696238B2 (en)	2010-04-13
PT1881967E (pt)	2010-06-30
JP2008540597A (ja)	2008-11-20
EP1888541A1 (de)	2008-02-20
EP1888541B1 (de)	2009-08-05
DE102005038947A1 (de)	2006-11-30
DE502006006854D1 (de)	2010-06-10
JP2008540598A (ja)	2008-11-20
WO2006122800A1 (de)	2006-11-23

Publication	Publication Date	Title
HK1112238A1 (en)	2008-08-29	Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
PL1891004T3 (pl)	2010-05-31	Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
MX2007003108A (es)	2007-05-24	Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MX2009003382A (es)	2009-04-08	Derivados de sulfonamidas sustituidos.
MX2011009369A (es)	2011-09-27	2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2009005461A (es)	2009-08-28	N-oxidos de analogos de 4,5-epoxi-morfinano.
MXPA06007171A (es)	2006-08-23	Derivados de ciclohexano espirociclicos con afinidad para el receptor orl1.
NO20083153L (no)	2008-09-22	Kjemiske forbindelser
MX2009004108A (es)	2009-04-28	Compuestos de tetrahidropirrolopiracina sustituidos teniendo afinidad al canal kcnq2/3 k+ y su uso en farmacos.
TNSN08024A1 (en)	2009-07-14	7-substituted aza-indazoles, compositions containing same, production method and use thereof
TW200800968A (en)	2008-01-01	Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX2009005462A (es)	2009-08-28	Analogos de 7,8-saturados-4,5-epoxi-morfinano.
TW200740814A (en)	2007-11-01	Compounds
RS20060250A (en)	2008-08-07	1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics
TW200700064A (en)	2007-01-01	Novel compounds
PL1888514T3 (pl)	2009-08-31	Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
MX2011008825A (es)	2011-09-21	3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
JO2682B1 (en)	2013-03-03	Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
DE602004024213D1 (en)	2009-12-31	Aminopropanolderivate
RS20070205A (en)	2008-11-28	5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
MY146671A (en)	2012-09-14	Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
WO2008131946A3 (de)	2009-03-19	Substituierte amid-derivate
MY144180A (en)	2011-08-15	Method for producing strontium ranelate and its hydrates
MX2011008662A (es)	2011-09-06	2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es)	2011-09-27	3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.